Aastha Binjrajka

Health and Adults Care Scrutiny Panel Co-Optee

Health and Adults Care Scrutiny Panel - Monday, 2 March 2026 7:00 pm

The Health and Adults Care Scrutiny Panel of Hounslow Council was scheduled to discuss feedback from a site visit to Multi-Disciplinary Teams at the Heart of Hounslow PCN, and to consider developing effective recommendations for the council's adult social care provision. The meeting also included a workshop to develop findings and recommendations, and a survey for members to suggest topics for the upcoming work programme.

Health and Adults Care Scrutiny Panel Co-Optee

Health and Adults Care Scrutiny Panel - Monday, 3 November 2025 7:00 pm

The Hounslow Council Health and Adults Care Scrutiny Panel met on Monday 3 November 2025 to discuss early evidence of the new model of care, and to plan future activities. The panel was also scheduled to review notes from a prior informal meeting.

Hounslow Health and Wellbeing Board Co-Optee

Hounslow Health and Wellbeing Board - Wednesday, 15 October 2025 4:00 pm

The Hounslow Health and Wellbeing Board met to discuss a range of topics, including updates on domiciliary care, extra care housing, and a hospital discharge pilot. The board was also scheduled to discuss the Better Care Fund, the Health and Wellbeing Strategy Progress Report, and the Joint Strategic Needs Assessment.

Health and Adults Care Scrutiny Panel Co-Optee

Health and Adults Care Scrutiny Panel - Tuesday, 9 September 2025 7:00 pm

The Hounslow Council's Health and Adults Care Scrutiny Panel met on Tuesday, 9 September 2025, to discuss several topics, including patient involvement, pressures in adult social care, and the terms of reference for a deep dive into adult social care services. The panel was also scheduled to hear from patient and resident representatives.

Hounslow Health and Wellbeing Board Co-Optee

Special, Hounslow Health and Wellbeing Board - Tuesday, 2 September 2025 6:15 pm

The Hounslow Health and Wellbeing Board met to discuss the approval and publication of the Pharmaceutical Needs Assessment 2025. The board was also scheduled to note the Monitoring Officer's guidance on declaring interests.